Lv1
40 积分 2024-11-04 加入
A Series of Novel, Highly Potent, and Orally Bioavailable Next-Generation Tricyclic Peptide PCSK9 Inhibitors
2天前
已完结
Series of Novel and Highly Potent Cyclic Peptide PCSK9 Inhibitors Derived from an mRNA Display Screen and Optimized via Structure-Based Design
2天前
已完结
In vivo chimeric antigen receptor (CAR)-T cell therapy
1个月前
已完结
In vivo CAR engineering for immunotherapy
1个月前
已完结
A new CHO (Chinese hamster ovary)-derived cell line expressing anti-TNFα monoclonal antibody with biosimilar potential
3个月前
已完结
Adiponectin receptors: A review of their structure, function and how they work
9个月前
已完结
Design of a brain-penetrant CDK4/6 inhibitor for glioblastoma
9个月前
已完结
Discovery of a Potent and Selective Inhibitor of Cyclin-Dependent Kinase 4/6
9个月前
已完结
Adagrasib in Non–Small-Cell Lung Cancer Harboring a KRASG12C Mutation
1年前
已完结
Anti-tumor efficacy of a potent and selective non-covalent KRASG12D inhibitor
1年前
已完结
皖公网安备34019202002308
